Progressive non-fluent aphasia (PNFA) is a neurodegenerative disease, a clinical subtype of primary progressive aphasia, characterized by gradually slowing, intermittent language expression and increasing grammatical errors. Current studies have shown that PNFA is mainly associated with abnormalities in tau protein and TAR DNA binding protein-43 (TDP-43), and may involve multiple protein pathologies. In terms of diagnosis, researchers have used imaging techniques such as magnetic resonance imaging (MRI), positron emission tomography (PET), and radiomics to discover specific brain structural changes in patients with PNFA, providing a basis for early diagnosis. In terms of treatment, speech and language therapy and non-invasive brain stimulation techniques (such as transcranial direct current stimulation and transcranial magnetic stimulation) have shown certain improvement effects, but the progress of pharmacotherapy is currently limited.